OpGen (OPGN) Announced 1-for-20 Reverse Stock Split
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Cerebras Systems falls as TD Cowen cuts price target
- Nasdaq climbs as chip and AI-linked stocks bounce back
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
- Moderna shares rise ahead of cancer vaccine trial results
OpGen Announced 1-for-20 Reverse Stock Split
January 4, 2023 4:30 PM ESTROCKVILLE, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, OpGen or the Company), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced that the Companys board of directors has approved a 1-for-20 reverse stock split of its shares of common stock (the Reverse Stock Split). The Reverse Stock Split will become effective at 12:01 a.m. EST, on January 5, 2023 and the Companys common stock will open for trading on The Nasdaq Capital Market on a post-split basis under the Companys existing trading symbol OPGN. The new CUSIP number for... More



